HEADER IMMUNE SYSTEM 04-JUL-17 5OCX TITLE CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CII-C-13-CIT COMPND MOL_ID: 1; COMPND 2 MOLECULE: FAB FRAGMENT ANTI-CITRULLINATED PROTEIN ANTIBODY E4 - LIGHT COMPND 3 CHAIN; COMPND 4 CHAIN: L; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: N-TERMINAL GLUTAMINE IS POSTTRANSLATIONALLY MODIFIED COMPND 7 TO PYROGLUTAMIC ACID PRODUCED AS CHIMERA OF HUMAN E4 MAB VARIABLE COMPND 8 DOMAINS AND MOUSE IGG2A CONSTANT DOMAINS; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: FAB FRAGMENT OF ANTI-CITRULLINATED PROTEIN ANTIBODY E4 - COMPND 11 HEAVY CHAIN; COMPND 12 CHAIN: H; COMPND 13 ENGINEERED: YES; COMPND 14 OTHER_DETAILS: UNMODELLED RESIDUES NOT VISIBLE IN ELECTRON DENSITY COMPND 15 PRODUCED AS CHIMERA OF HUMAN MAB E4 VARIABLE DOMAINS AND MOUSE IGG2A COMPND 16 CONSTANT DOMAINS; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: CII-C-13-CIT; COMPND 19 CHAIN: A; COMPND 20 ENGINEERED: YES; COMPND 21 OTHER_DETAILS: CITRULLINATED EPITOPE DERIVED FROM HUMAN COLLAGEN TYPE COMPND 22 II BIOTIN AND AMINOHEXANOIC ACID ATTACHED AT N-TERMINUS CIRCULARIZED COMPND 23 VIA DISULFIDE BRIDGE FORMATION BETWEEN THE TWO CYSTEINES UNMODELLED COMPND 24 RESIDUES NOT VISIBLE IN ELECTRON DENSITY MAP SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: B CELLS; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL: EXPI293F (TM); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PCEP4; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 CELL_LINE: B CELLS; SOURCE 16 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 17 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 19 EXPRESSION_SYSTEM_CELL: EXPI293F (TM); SOURCE 20 EXPRESSION_SYSTEM_VECTOR_TYPE: PCEP4; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES; SOURCE 23 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 24 ORGANISM_COMMON: HUMAN; SOURCE 25 ORGANISM_TAXID: 9606 KEYWDS ANTI-CITRULLINATED PROTEIN ANTIBODY FAB FRAGMENT, COLLAGEN TYPE II KEYWDS 2 EPITOPE IMMUNE SYSTEM, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR D.DOBRITZSCH,C.GE,R.HOLMDAHL REVDAT 5 17-JAN-24 5OCX 1 REMARK REVDAT 4 15-NOV-23 5OCX 1 LINK ATOM REVDAT 3 11-MAR-20 5OCX 1 JRNL SEQRES REVDAT 2 07-AUG-19 5OCX 1 JRNL REVDAT 1 04-JUL-18 5OCX 0 JRNL AUTH C.GE,B.XU,B.LIANG,E.LONNBLOM,S.L.LUNDSTROM,R.A.ZUBAREV, JRNL AUTH 2 B.AYOGLU,P.NILSSON,T.SKOGH,A.KASTBOM,V.MALMSTROM, JRNL AUTH 3 L.KLARESKOG,R.E.M.TOES,T.RISPENS,D.DOBRITZSCH,R.HOLMDAHL JRNL TITL STRUCTURAL BASIS OF CROSS-REACTIVITY OF ANTI-CITRULLINATED JRNL TITL 2 PROTEIN ANTIBODIES. JRNL REF ARTHRITIS RHEUMATOL V. 71 210 2019 JRNL REFN ISSN 2326-5191 JRNL PMID 30152126 JRNL DOI 10.1002/ART.40698 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.23 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 35680 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1948 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2445 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.26 REMARK 3 BIN R VALUE (WORKING SET) : 0.3050 REMARK 3 BIN FREE R VALUE SET COUNT : 134 REMARK 3 BIN FREE R VALUE : 0.3040 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3356 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 4 REMARK 3 SOLVENT ATOMS : 400 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.11 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.19000 REMARK 3 B22 (A**2) : -2.03000 REMARK 3 B33 (A**2) : 1.30000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.04000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.137 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.125 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.108 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.629 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3509 ; 0.009 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 3113 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4804 ; 1.428 ; 1.948 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7285 ; 1.581 ; 2.999 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 467 ; 6.606 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 130 ;31.371 ;23.385 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 540 ;11.687 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;22.595 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 542 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3921 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 709 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1802 ; 1.337 ; 2.230 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1801 ; 1.334 ; 2.228 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2252 ; 2.193 ; 3.334 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2253 ; 2.195 ; 3.335 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1707 ; 1.532 ; 2.338 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1707 ; 1.531 ; 2.338 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2540 ; 2.443 ; 3.437 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3957 ; 4.627 ;27.067 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 3958 ; 4.627 ;27.069 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5OCX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-JUL-17. REMARK 100 THE DEPOSITION ID IS D_1200005598. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JAN-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37660 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 45.230 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.58400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4M1Q,3LMJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 32.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.82 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% (W/V) PEG3350, 0.2 M AMMONIUM REMARK 280 CITRATE DIBASIC, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 49.80100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP H 137 REMARK 465 THR H 138 REMARK 465 PRO H 221 REMARK 465 CYS A 1 REMARK 465 PRO A 2 REMARK 465 ALA A 3 REMARK 465 GLU A 14 REMARK 465 PRO A 15 REMARK 465 GLY A 16 REMARK 465 CYS A 17 REMARK 465 ALA A 18 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH H 513 O HOH H 558 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG H 67 NE - CZ - NH2 ANGL. DEV. = 3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP L 26 -114.80 39.55 REMARK 500 ASP L 52 -47.70 71.87 REMARK 500 ALA L 85 169.13 179.31 REMARK 500 ALA L 91 146.89 -174.00 REMARK 500 SER L 174 19.48 58.81 REMARK 500 SER H 15 -5.76 80.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO H 301 DBREF 5OCX L 1 217 PDB 5OCX 5OCX 1 217 DBREF 5OCX H 1 221 PDB 5OCX 5OCX 1 221 DBREF 5OCX A 1 18 PDB 5OCX 5OCX 1 18 SEQRES 1 L 217 PCA SER VAL TRP THR GLN PRO PRO SER VAL SER ALA ALA SEQRES 2 L 217 PRO GLY GLN LYS VAL THR ILE SER CYS SER GLY ASP ASP SEQRES 3 L 217 SER ILE LEU ARG SER ALA PHE VAL SER TRP TYR GLN GLN SEQRES 4 L 217 VAL PRO GLY SER ALA PRO LYS LEU VAL ILE PHE ASP ASP SEQRES 5 L 217 ARG GLN ARG PRO SER GLY ILE PRO ALA ARG PHE SER GLY SEQRES 6 L 217 SER ASN SER GLY THR THR ALA THR LEU ASP ILE ALA GLY SEQRES 7 L 217 LEU GLN ARG GLY ASP GLU ALA ASP TYR TYR CYS ALA ALA SEQRES 8 L 217 TRP ASN GLY ARG LEU SER ALA PHE VAL PHE GLY SER GLY SEQRES 9 L 217 THR LYS LEU GLU ILE LYS ARG ALA ASP ALA ALA PRO THR SEQRES 10 L 217 VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU THR SER SEQRES 11 L 217 GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN PHE TYR SEQRES 12 L 217 PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP GLY SER SEQRES 13 L 217 GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR ASP GLN SEQRES 14 L 217 ASP SER LYS ASP SER THR TYR SER MET SER SER THR LEU SEQRES 15 L 217 THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SER TYR SEQRES 16 L 217 THR CYS GLU ALA THR HIS LYS THR SER THR SER PRO ILE SEQRES 17 L 217 VAL LYS SER PHE ASN ARG ASN GLU CYS SEQRES 1 H 221 GLN VAL GLN LEU GLU GLU SER GLY PRO GLY LEU VAL ARG SEQRES 2 H 221 PRO SER GLU THR LEU SER LEU SER CYS THR VAL SER GLY SEQRES 3 H 221 PHE PRO MET SER GLU SER TYR PHE TRP GLY TRP ILE ARG SEQRES 4 H 221 GLN SER PRO GLY LYS GLY LEU GLU TRP LEU GLY SER VAL SEQRES 5 H 221 ILE HIS THR GLY THR THR TYR TYR ARG PRO SER LEU GLU SEQRES 6 H 221 SER ARG LEU THR ILE ALA MET ASP PRO SER LYS ASN GLN SEQRES 7 H 221 VAL SER LEU SER LEU THR SER VAL THR VAL ALA ASP SER SEQRES 8 H 221 ALA MET TYR TYR CYS VAL ARG ILE ARG GLY GLY SER SER SEQRES 9 H 221 ASN TRP LEU ASP PRO TRP GLY PRO GLY ILE VAL VAL THR SEQRES 10 H 221 ALA SER SER ALA LYS THR THR PRO PRO SER VAL TYR PRO SEQRES 11 H 221 LEU ALA PRO GLY CYS GLY ASP THR THR GLY SER SER VAL SEQRES 12 H 221 THR LEU GLY CYS LEU VAL LYS GLY TYR PHE PRO GLU SER SEQRES 13 H 221 VAL THR VAL THR TRP ASN SER GLY SER LEU SER SER SER SEQRES 14 H 221 VAL HIS THR PHE PRO ALA LEU LEU GLN SER GLY LEU TYR SEQRES 15 H 221 THR MET SER SER SER VAL THR VAL PRO SER SER THR TRP SEQRES 16 H 221 PRO SER GLN THR VAL THR CYS SER VAL ALA HIS PRO ALA SEQRES 17 H 221 SER SER THR THR VAL ASP LYS LYS ILE GLU PRO ARG PRO SEQRES 1 A 18 CYS PRO ALA GLY GLU GLU GLY LYS CIR GLY ALA ARG GLY SEQRES 2 A 18 GLU PRO GLY CYS ALA HET PCA L 1 8 HET CIR A 9 11 HET EDO H 301 4 HETNAM PCA PYROGLUTAMIC ACID HETNAM CIR CITRULLINE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 PCA C5 H7 N O3 FORMUL 3 CIR C6 H13 N3 O3 FORMUL 4 EDO C2 H6 O2 FORMUL 5 HOH *400(H2 O) HELIX 1 AA1 SER L 27 ALA L 32 5 6 HELIX 2 AA2 GLN L 80 GLU L 84 5 5 HELIX 3 AA3 SER L 124 SER L 130 1 7 HELIX 4 AA4 LYS L 186 ARG L 191 1 6 HELIX 5 AA5 ASN L 215 CYS L 217 5 3 HELIX 6 AA6 PRO H 62 GLU H 65 5 4 HELIX 7 AA7 THR H 87 SER H 91 5 5 HELIX 8 AA8 PRO H 207 SER H 210 5 4 HELIX 9 AA9 GLY A 4 LYS A 8 5 5 SHEET 1 AA1 5 SER L 9 ALA L 12 0 SHEET 2 AA1 5 THR L 105 ILE L 109 1 O GLU L 108 N VAL L 10 SHEET 3 AA1 5 ALA L 85 ASN L 93 -1 N ALA L 85 O LEU L 107 SHEET 4 AA1 5 SER L 35 GLN L 39 -1 N GLN L 39 O ASP L 86 SHEET 5 AA1 5 LYS L 46 ILE L 49 -1 O VAL L 48 N TRP L 36 SHEET 1 AA2 4 SER L 9 ALA L 12 0 SHEET 2 AA2 4 THR L 105 ILE L 109 1 O GLU L 108 N VAL L 10 SHEET 3 AA2 4 ALA L 85 ASN L 93 -1 N ALA L 85 O LEU L 107 SHEET 4 AA2 4 ALA L 98 PHE L 101 -1 O ALA L 98 N ASN L 93 SHEET 1 AA3 3 VAL L 18 SER L 23 0 SHEET 2 AA3 3 THR L 71 ILE L 76 -1 O ALA L 72 N CYS L 22 SHEET 3 AA3 3 PHE L 63 ASN L 67 -1 N SER L 64 O ASP L 75 SHEET 1 AA4 4 THR L 117 PHE L 121 0 SHEET 2 AA4 4 GLY L 132 PHE L 142 -1 O VAL L 136 N PHE L 121 SHEET 3 AA4 4 TYR L 176 THR L 185 -1 O MET L 178 N LEU L 139 SHEET 4 AA4 4 VAL L 162 TRP L 166 -1 N LEU L 163 O THR L 181 SHEET 1 AA5 4 SER L 156 ARG L 158 0 SHEET 2 AA5 4 ASN L 148 ILE L 153 -1 N ILE L 153 O SER L 156 SHEET 3 AA5 4 SER L 194 THR L 200 -1 O GLU L 198 N LYS L 150 SHEET 4 AA5 4 ILE L 208 ASN L 213 -1 O ILE L 208 N ALA L 199 SHEET 1 AA6 4 GLN H 3 SER H 7 0 SHEET 2 AA6 4 LEU H 18 SER H 25 -1 O SER H 25 N GLN H 3 SHEET 3 AA6 4 GLN H 78 LEU H 83 -1 O LEU H 83 N LEU H 18 SHEET 4 AA6 4 LEU H 68 ASP H 73 -1 N ALA H 71 O SER H 80 SHEET 1 AA7 6 LEU H 11 VAL H 12 0 SHEET 2 AA7 6 ILE H 114 ALA H 118 1 O THR H 117 N VAL H 12 SHEET 3 AA7 6 ALA H 92 ARG H 100 -1 N TYR H 94 O ILE H 114 SHEET 4 AA7 6 PHE H 34 GLN H 40 -1 N PHE H 34 O ILE H 99 SHEET 5 AA7 6 LEU H 46 VAL H 52 -1 O GLU H 47 N ARG H 39 SHEET 6 AA7 6 THR H 58 TYR H 60 -1 O TYR H 59 N SER H 51 SHEET 1 AA8 4 LEU H 11 VAL H 12 0 SHEET 2 AA8 4 ILE H 114 ALA H 118 1 O THR H 117 N VAL H 12 SHEET 3 AA8 4 ALA H 92 ARG H 100 -1 N TYR H 94 O ILE H 114 SHEET 4 AA8 4 TRP H 106 TRP H 110 -1 O TRP H 106 N ARG H 100 SHEET 1 AA9 4 SER H 127 LEU H 131 0 SHEET 2 AA9 4 SER H 142 TYR H 152 -1 O LYS H 150 N SER H 127 SHEET 3 AA9 4 LEU H 181 PRO H 191 -1 O MET H 184 N VAL H 149 SHEET 4 AA9 4 SER H 169 THR H 172 -1 N HIS H 171 O SER H 187 SHEET 1 AB1 4 SER H 127 LEU H 131 0 SHEET 2 AB1 4 SER H 142 TYR H 152 -1 O LYS H 150 N SER H 127 SHEET 3 AB1 4 LEU H 181 PRO H 191 -1 O MET H 184 N VAL H 149 SHEET 4 AB1 4 LEU H 176 GLN H 178 -1 N GLN H 178 O LEU H 181 SHEET 1 AB2 3 THR H 158 ASN H 162 0 SHEET 2 AB2 3 THR H 201 HIS H 206 -1 O THR H 201 N ASN H 162 SHEET 3 AB2 3 THR H 211 LYS H 216 -1 O THR H 211 N HIS H 206 SSBOND 1 CYS L 22 CYS L 89 1555 1555 2.05 SSBOND 2 CYS L 137 CYS L 197 1555 1555 2.03 SSBOND 3 CYS L 217 CYS H 135 1555 1555 2.06 SSBOND 4 CYS H 22 CYS H 96 1555 1555 2.02 SSBOND 5 CYS H 147 CYS H 202 1555 1555 2.03 LINK C PCA L 1 N SER L 2 1555 1555 1.33 LINK C LYS A 8 N CIR A 9 1555 1555 1.33 LINK C CIR A 9 N GLY A 10 1555 1555 1.32 CISPEP 1 TYR L 143 PRO L 144 0 1.96 CISPEP 2 ASP H 108 PRO H 109 0 2.18 CISPEP 3 PHE H 153 PRO H 154 0 -4.61 CISPEP 4 GLU H 155 SER H 156 0 2.08 CISPEP 5 TRP H 195 PRO H 196 0 12.59 SITE 1 AC1 6 TRP H 106 ASP H 108 HOH H 405 HOH H 478 SITE 2 AC1 6 HOH H 486 PHE L 50 CRYST1 38.716 99.602 51.877 90.00 101.88 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025829 0.000000 0.005434 0.00000 SCALE2 0.000000 0.010040 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019698 0.00000 HETATM 1 N PCA L 1 41.799 28.637 9.576 1.00 22.65 N HETATM 2 CA PCA L 1 42.651 27.596 9.002 1.00 21.94 C HETATM 3 CB PCA L 1 43.506 27.139 10.206 1.00 23.12 C HETATM 4 CG PCA L 1 42.631 27.498 11.408 1.00 22.61 C HETATM 5 CD PCA L 1 41.719 28.588 10.904 1.00 22.66 C HETATM 6 OE PCA L 1 40.984 29.303 11.593 1.00 22.65 O HETATM 7 C PCA L 1 41.799 26.440 8.433 1.00 21.19 C HETATM 8 O PCA L 1 40.621 26.274 8.807 1.00 19.68 O